The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Started
2025-08-31
Last updated
2025-08-11
Condition(s) studied
Severe PneumoniaBacterial Infections
Study summary
AI-ROSE is an innovative immunofluorescence staining combined with artificial intelligence image analysis technology that uses a fully automated fluorescence microscope to image pathogens in real time. AI algorithms automatically identify pathogen types (such as bacteria, fungi, etc.) and cellular backgrounds, quickly interpret results, and automatically issue color graphic reports for clinical doctors to take earlier and more accurate targeted treatment for critically ill patients. This study used bronchoalveolar lavage fluid as a biological sample and compared it with traditional examination methods to analyze the diagnostic accuracy and clinical practicality of AI-ROSE in patients with severe pneumonia.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Age 18 years and above
* The preliminary clinical diagnosis is a patient with lower respiratory tract infection
* Meets the criteria for severe pneumonia, which means one of the following conditions exists: ① Main criteria: septic shock requiring vasoactive drug support; Respiratory failure requiring mechanical ventilation; ② Secondary criteria: Meet at least 3 or more criteria, including respiratory rate\>30 times/minute; Oxygenation index (PaO ₂/FiO ₂)\<250; Multiple leaf segment infiltration; Consciousness disorders/orientation disorders; Urea nitrogen level\>20mg/dL; White blood cell count\<4 \* 10 \^ 9/L; platelet count\<100 \* 10 \^ 9/L; core body temperature\<36.8 ° C; hypotension requiring active fluid resuscitation
* The patient agrees to undergo bronchoscopy and bronchoalveolar lavage, and agrees to perform AI-ROSE testing on the bronchoalveolar lavage fluid
Exclusion Criteria:
* Patients with poor basic condition, severe illness, and inability to tolerate bronchoscopy examination
* The bronchoalveolar lavage fluid sample is not qualified
Primary outcome measure(s)
Comparing the diagnostic accuracy of AI-ROSE with traditional bronchoalveolar lavage fluid examination methods. — 2026-3-31
Trial sites (1)
Facility
City
Region
Status
Fluorescence Biological Microscope
Nanjing
Jiangsu
More The First Affiliated Hospital with Nanjing Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.